Indication
Treatment of adult patients with progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma.
Loading your page…
Loading your page…
Thyroid Neoplasms
Marketing Authorisation Holder: Ipsen Pharma
EMA Authorisation: 21/03/2014
INN: cabozantinib
AI Drug & Interaction Analysis
Free account required
Ask Osler about Cometriq: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.